Intuitive Surgical, Inc. develops, manufactures, and markets products aimed at enhancing minimally invasive surgical care. Its primary customers include hospitals and healthcare providers in the U.S. and internationally. The main products include the da Vinci Surgical System and the Ion endoluminal system, along with a suite of surgical instruments and support services. Revenue is primarily generated from system sales (approximately 60%), instruments and accessories (around 30%), and services (about 10%). Factors supporting endurance include the growing demand for minimally invasive procedures and the company's established reputation, while potential limitations include high competition and regulatory challenges in the healthcare sector.
—
Intuitive Surgical, Inc. develops, manufactures, and markets products aimed at enhancing minimally invasive surgical care. Its primary customers include hospitals and healthcare providers in the U.S. and internationally. The main products include the da Vinci Surgical System and the Ion endoluminal system, along with a suite of surgical instruments and support services. Revenue is primarily generated from system sales (approximately 60%), instruments and accessories (around 30%), and services (about 10%). Factors supporting endurance include the growing demand for minimally invasive procedures and the company's established reputation, while potential limitations include high competition and regulatory challenges in the healthcare sector.
—
Daily adjusted close
Intuitive Surgical, Inc. develops, manufactures, and markets products aimed at enhancing minimally invasive surgical care. Its primary customers include hospitals and healthcare providers in the U.S. and internationally. The main products include the da Vinci Surgical System and the Ion endoluminal system, along with a suite of surgical instruments and support services. Revenue is primarily generated from system sales (approximately 60%), instruments and accessories (around 30%), and services (about 10%). Factors supporting endurance include the growing demand for minimally invasive procedures and the company's established reputation, while potential limitations include high competition and regulatory challenges in the healthcare sector.